SaMD market to reach $120.54 billion by 2030

The Software as a Medical Device market is projected to jump from $38.02 billion in 2025 to $47.26 billion in 2026, according to The Business Research Company. Growth is being driven by telemedicine, remote care demand and digital health spending, with Asia-Pacific expected to post the fastest gains through 2030.

Why it matters: - SaMD is moving from niche software to a core part of digital healthcare delivery. - The market’s rapid growth points to bigger demand for remote monitoring, diagnostics and care management tools. - Health systems and vendors are also facing a faster shift toward cloud platforms, electronic health record integration and software-driven clinical workflows.

What happened: - The Business Research Company released a 2026 market report on Software as a Medical Device, or SaMD. - The report pegs the global SaMD market at $38.02 billion in 2025 and $47.26 billion in 2026. - The report forecasts the market will reach $120.54 billion by 2030. - The report was published on August 27, 2026. - A free sample report is available here: Download the sample report. - The full report is available here: View the full report.

The details: - SaMD refers to software designed for medical purposes without depending on a physical medical device. - The software can diagnose, treat or monitor medical conditions. - The market’s 2025 to 2026 growth reflects a 24.3% compound annual growth rate. - The forecast through 2030 implies a 26.4% CAGR. - Key growth drivers include telemedicine adoption, smartphone usage, digital health funding, clearer regulation and demand for remote healthcare services. - Future growth is tied to virtual care, software-driven diagnostics, cloud-based healthcare platforms, outcome-based reimbursement and hospital software modernization. - Expected trends include expanded clinical decision support tools, more remote diagnostic applications, broader regulatory approvals, subscription-based SaMD models and deeper electronic health record integration.

Between the lines: - Chronic disease management remains a major demand driver because SaMD can support continuous monitoring and earlier intervention. - The report points to the shift from episodic care to always-on digital care, which favors software that can scale across patients and providers. - North America led the market in 2025 because of stronger infrastructure, supportive regulation and early technology adoption. - Asia-Pacific is expected to grow fastest during the forecast period because of expanding healthcare access, higher digital literacy and more investment in health technology. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics.

What's next: - SaMD vendors are likely to keep pushing into remote diagnostics, clinical decision support and cloud-connected care tools. - Hospitals and health systems will face more pressure to modernize software stacks and connect medical software with existing records and reimbursement models. - Regional growth will likely remain uneven, with North America holding scale and Asia-Pacific leading expansion.

The bottom line: - SaMD is on track for very fast growth as digital healthcare moves deeper into routine medical care.